Medicine
| ISSN | 24681253 |
|---|---|
| Country | United Kingdom |
| Publisher | Elsevier Ltd. |
| Subject Areas | Medicine |
| Publication Type | Journals |
| Active Years | 2016-2021 |
| Website | Visit journal |
| JIF 2022–2023 | 30.900 |
Each monthly issue of The Lancet GastroenterologyHepatology features original clinical research expert reviews news and provocative comment and opinion in gastroenterology and hepatology providing a clear independent perspective about the clinical advances and practicechanging research shaping your specialty globally. The journal publishes papers that reflect the rich variety of ongoing clinical research in gastroenterology and hepatology in particular in the areas of inflammatory bowel diseases NAFLD and NASH functional gastrointestinal disorders gastrointestinal and hepatopancreatobiliary cancers and viral hepatitis.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2022 | 10.723 | 9.483 | 8.885 |
| 2021 | 11.770 | 10.374 | 9.546 |
| 2020 | 5.018 | 5.315 | 5.625 |
| 2019 | 5.153 | 5.533 | 5.533 |
| 2018 | 5.112 | 5.112 | 5.112 |
| 2017 | 3.967 | 3.967 | 3.967 |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 8.957 |
| 2022 | 6.174 |
| 2021 | 5.927 |
| 2020 | 4.897 |
| 2019 | 5.299 |
| 2018 | 5.048 |
| 2017 | 2.670 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 105.000 |
| 2022 | 84.000 |
| 2021 | 66.000 |
https://ees.elsevier.com/thelancetgastrohep/